Clinical Trial Update: Safety Study of GSK Biologicals' HPV Vaccine (GSK-580299) in Healthy Female Subjects. [Phase 3]

View source ↗

Summary

Phase 3 safety study of GlaxoSmithKline's HPV vaccine (GSK-580299) in healthy female subjects, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Papillomavirus Infection

Drugs mentioned

• Cervarix (human papillomavirus vaccine, bivalent)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Papillomavirus | Phase 3 | Status: COMPLETED | Results posted: 2011-10-13